Latest news
Tarsus pays $450M for Alkeus and its ph. 3 retinal disease drug - Fierce BiotechFierce Biotech · Thu, 06 Aug 2026 14:30:00 GMTEvidence on Gene Therapy for Pediatric IRDs Remains Uneven - Review of OptometryReview of Optometry · Wed, 05 Aug 2026 10:04:22 GMTOpus Genetics Completes Enrollment in Phase 3 Trial of Gene Therapy for Inherited Retinal Disease - Eyewire+Eyewire+ · Tue, 04 Aug 2026 13:06:40 GMTWhy inherited retinal disease treatment requires more than gene therapy - Drug Target ReviewDrug Target Review · Tue, 04 Aug 2026 08:55:59 GMTA Race Against Blindness Launches New Research Grants Program to Accelerate Treatments for Inherited Retinal Diseases and Bardet-Biedl Syndrome - The Manila TimesThe Manila Times · Mon, 03 Aug 2026 17:49:01 GMTCollagen mimetic peptide shows early neuroprotective signals in inherited retinal disease models | OIS Retina 2026 - Ophthalmology Times EuropeOphthalmology Times Europe · Mon, 03 Aug 2026 14:03:11 GMTOpus Genetics Completes Enrollment in Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 11:15:00 GMTOpus Genetics Completes Patient Enrollment in Registrational Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 11:00:00 GMT